Trial Profile
Pilot Examination of Galantamine in the Management of Tic Disorders.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 08 Sep 2009
Price :
$35
*
At a glance
- Drugs Galantamine (Primary)
- Indications Tic disorders
- Focus Adverse reactions; Therapeutic Use
- 24 Dec 2005 New trial record.